- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 38/15 - DepsipeptidesLeurs dérivés
Détention brevets de la classe A61K 38/15
Brevets de cette classe: 347
Historique des publications depuis 10 ans
|
19
|
26
|
28
|
31
|
30
|
28
|
24
|
20
|
25
|
25
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Pharma Mar, S.A. | 215 |
27 |
| Celgene Corporation | 1405 |
17 |
| Bayer Animal Health GmbH | 219 |
11 |
| Boehringer Ingelheim Animal Health USA Inc. | 421 |
10 |
| Onkure, Inc. | 28 |
9 |
| St. Jude Children's Research Hospital | 241 |
8 |
| University of Florida Research Foundation, Inc. | 4074 |
7 |
| Zoetis Services LLC | 1531 |
7 |
| The Trustees of Columbia University in the City of New York | 3595 |
6 |
| Celgene Quanticel Research, Inc. | 162 |
6 |
| NovoBiotic Pharmaceuticals, LLC | 22 |
6 |
| Trustees of Boston University | 988 |
6 |
| Fleurir ABX LLC | 12 |
5 |
| Viracta Subsidiary, Inc | 20 |
5 |
| Novartis AG | 10656 |
4 |
| Chung-Ang University Industry-Academy Cooperation Foundation | 438 |
4 |
| Desert King International, LLC | 37 |
4 |
| The Kitasato Institute | 155 |
4 |
| Reapplix ApS | 24 |
4 |
| The Regents of the University of Colorado, a body corporate | 2703 |
4 |
| Autres propriétaires | 193 |